SCHEMBL3358898

SCHEMBL3358898

CCOC(=O)c1ccc([N+](=O)[O-])c(NC2CCN(C)CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 5/20 0.51
MAPT P10636 4/20 0.51
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
PKM P14618 1/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
LMNA P02545 5/20 0.50
POLB P06746 2/20 0.50
ALOX15 P16050 2/20 0.50
KDM4E B2RXH2 1/20 0.50
PTGER4 P35408 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.46
HCAR3 P49019 3/20 0.46
KCNJ1 P48048 1/20 0.44
KCNH2 Q12809 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22382467 0.92 KMT2A (0.60) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL4124929 0.88 ALOX15 (0.65) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL22725419 0.87 KMT2A (0.54) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL22382328 0.85 KMT2A (0.58) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL3353065 0.85 MAPT (0.51) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL3353106 0.82 ALOX15 (0.63) LMNAALOX15PTGER4
SCHEMBL15319957 0.82 MAPT (0.66) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL15321361 0.82 HCAR3 (0.68) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL19245337 0.82 ALOX15 (0.59) RAB9AALOX15PTGER4
SCHEMBL13537290 0.81 ALOX15 (0.52) ALDH1A1MAPTALOX15PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed